Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup Arbor
In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory ...
Tag: Arbor
CRISPR company Arbor Biotechnologies gets cash infusion
Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!